191 related articles for article (PubMed ID: 30659395)
41. Phenotypic and histologic characteristics of cutaneous melanoma in patients with melanocortin-1 receptor polymorphisms.
Avilés JA; Lázaro P; Fernández LP; Benítez J; Ibarrola-Villava M; Ribas G
Actas Dermosifiliogr; 2012 Jan; 103(1):44-50. PubMed ID: 22464597
[TBL] [Abstract][Full Text] [Related]
42. MC1R genotype as a predictor of early-onset melanoma, compared with self-reported and physician-measured traditional risk factors: an Australian case-control-family study.
Cust AE; Goumas C; Vuong K; Davies JR; Barrett JH; Holland EA; Schmid H; Agha-Hamilton C; Armstrong BK; Kefford RF; Aitken JF; Giles GG; Bishop D; Newton-Bishop JA; Hopper JL; Mann GJ; Jenkins MA
BMC Cancer; 2013 Sep; 13():406. PubMed ID: 24134749
[TBL] [Abstract][Full Text] [Related]
43. Prevalence and Preliminary Validation of Screening Criteria to Identify Carriers of Germline BAP1 Mutations.
Zauderer MG; Jayakumaran G; DuBoff M; Zhang L; Francis JH; Abramson DH; Cercek A; Nash GM; Shoushtari A; Chapman P; D'Angelo S; Arnold AG; Siegel B; Fleischut MH; Ni A; Rimner A; Rusch VW; Adusumilli PS; Travis W; Sauter JL; Zehir A; Mandelker D; Ladanyi M; Robson M
J Thorac Oncol; 2019 Nov; 14(11):1989-1994. PubMed ID: 31323388
[TBL] [Abstract][Full Text] [Related]
44. The susceptibility CDKN2 locus may have a role on prognosis of melanoma patients.
Casula M; Budroni M; Cossu A; Ascierto PA; Mozzillo N; Canzanella S; Muggiano A; Palmieri G
Ann Oncol; 2010 Jun; 21(6):1379-1380. PubMed ID: 20231302
[No Abstract] [Full Text] [Related]
45. BAP1-inactivated spitzoid naevi.
Vilain RE; McCarthy SW; Thompson JF; Scolyer RA
Am J Surg Pathol; 2015 May; 39(5):722. PubMed ID: 25871468
[No Abstract] [Full Text] [Related]
46. Melanoma genetics: a review of genetic factors and clinical phenotypes in familial melanoma.
Pho L; Grossman D; Leachman SA
Curr Opin Oncol; 2006 Mar; 18(2):173-9. PubMed ID: 16462187
[TBL] [Abstract][Full Text] [Related]
47. Surveillance for familial melanoma: recommendations from a national centre of expertise.
Halk AB; Potjer TP; Kukutsch NA; Vasen HFA; Hes FJ; van Doorn R
Br J Dermatol; 2019 Sep; 181(3):594-596. PubMed ID: 30742720
[No Abstract] [Full Text] [Related]
48. [Molecular diagnostics in melanoma].
Lang R; Bauer JW; Laimer M
Hautarzt; 2015 Apr; 66(4):277-81. PubMed ID: 25783213
[TBL] [Abstract][Full Text] [Related]
49. BAP1 deficient malignant melanoma arising from the intradermal component of a congenital melanocytic naevus.
Ardakani NM; Palmer DL; Wood BA
Pathology; 2015 Dec; 47(7):707-10. PubMed ID: 26517632
[No Abstract] [Full Text] [Related]
50. Marshaling the Translational Potential of
Kanetsky PA; Hay JL
Cancer Prev Res (Phila); 2018 Mar; 11(3):121-124. PubMed ID: 29246956
[TBL] [Abstract][Full Text] [Related]
51. Comprehensive Genetic Landscape of Uveal Melanoma by Whole-Genome Sequencing.
Royer-Bertrand B; Torsello M; Rimoldi D; El Zaoui I; Cisarova K; Pescini-Gobert R; Raynaud F; Zografos L; Schalenbourg A; Speiser D; Nicolas M; Vallat L; Klein R; Leyvraz S; Ciriello G; Riggi N; Moulin AP; Rivolta C
Am J Hum Genet; 2016 Nov; 99(5):1190-1198. PubMed ID: 27745836
[TBL] [Abstract][Full Text] [Related]
52. Multiple primary melanomas versus single melanoma of the head and neck: a comparison of genetic, diagnostic, and therapeutic implications.
Pollio A; Tomasi A; Pellacani G; Ruini C; Mandel VD; Fortuna G; Seidenari S; Ponti G
Melanoma Res; 2014 Jun; 24(3):267-72. PubMed ID: 24638154
[TBL] [Abstract][Full Text] [Related]
53. Early onset may predict G101W CDKN2A founder mutation carrier status in Ligurian melanoma patients.
Mantelli M; Pastorino L; Ghiorzo P; Barile M; Bruno W; Gargiulo S; Sormani MP; Gliori S; Vecchio S; Ciotti P; Sertoli MR; Queirolo P; Goldstein AM; Bianchi-Scarrà G;
Melanoma Res; 2004 Dec; 14(6):443-8. PubMed ID: 15577313
[TBL] [Abstract][Full Text] [Related]
54. Correlation of Gene Mutation Status with Copy Number Profile in Uveal Melanoma.
Yavuzyigitoglu S; Drabarek W; Smit KN; van Poppelen N; Koopmans AE; Vaarwater J; Brands T; Eussen B; Dubbink HJ; van Riet J; van de Werken HJ; Beverloo B; Verdijk RM; Naus N; Paridaens D; Kilic E; de Klein A;
Ophthalmology; 2017 Apr; 124(4):573-575. PubMed ID: 27916271
[No Abstract] [Full Text] [Related]
55. A novel SVM-ID3 hybrid feature selection method to build a disease model for melanoma using integrated genotyping and phenotype data from dbGaP.
Son YA; Yücebaş SC
Stud Health Technol Inform; 2014; 205():501-5. PubMed ID: 25160235
[TBL] [Abstract][Full Text] [Related]
56. Whole Exome Sequencing Identifies Candidate Genes Associated with Hereditary Predisposition to Uveal Melanoma.
Abdel-Rahman MH; Sample KM; Pilarski R; Walsh T; Grosel T; Kinnamon D; Boru G; Massengill JB; Schoenfield L; Kelly B; Gordon D; Johansson P; DeBenedictis MJ; Singh A; Casadei S; Davidorf FH; White P; Stacey AW; Scarth J; Fewings E; Tischkowitz M; King MC; Hayward NK; Cebulla CM
Ophthalmology; 2020 May; 127(5):668-678. PubMed ID: 32081490
[TBL] [Abstract][Full Text] [Related]
57. Genome-wide association studies in melanoma: off to a good start.
Kim HK; Chanock SJ
Pigment Cell Melanoma Res; 2012 Mar; 25(2):231-3. PubMed ID: 22268896
[No Abstract] [Full Text] [Related]
58. Re: MC1R, ASIP, and DNA repair in sporadic and familial melanoma in a Mediterranean population.
Fargnoli MC; Spica T; Sera F; Pellacani G; Chiarugi A; Seidenari S; Carli P; Chimenti S; Peris K
J Natl Cancer Inst; 2006 Jan; 98(2):144-5; author reply 145-6. PubMed ID: 16418518
[No Abstract] [Full Text] [Related]
59. Childhood melanoma: what every pediatrician should know.
Dinulos J
Curr Opin Pediatr; 2009 Aug; 21(4):472-4. PubMed ID: 19617832
[No Abstract] [Full Text] [Related]
60. Familial skin cancer syndromes: Increased melanoma risk.
Ransohoff KJ; Jaju PD; Tang JY; Carbone M; Leachman S; Sarin KY
J Am Acad Dermatol; 2016 Mar; 74(3):423-34; quiz 435-6. PubMed ID: 26892652
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
